Follow
Mic Lajiness
Mic Lajiness
Verified email at lilly.com
Title
Cited by
Cited by
Year
Navigating structure–activity landscapes
J Bajorath, L Peltason, M Wawer, R Guha, MS Lajiness, JH Van Drie
Drug discovery today 14 (13-14), 698-705, 2009
1852009
Assessment of the consistency of medicinal chemists in reviewing sets of compounds
MS Lajiness, GM Maggiora, V Shanmugasundaram
Journal of medicinal chemistry 47 (20), 4891-4896, 2004
1692004
Molecular properties that influence oral drug-like behavior.
MS Lajiness, M Vieth, J Erickson
Current opinion in drug discovery & development 7 (4), 470-477, 2004
1512004
Approaches to virtual library design
JH Van Drie, MS Lajiness
Drug Discovery Today 3 (6), 274-283, 1998
1261998
Dissimilarity-based compound selection techniques
MS Lajiness
Perspectives in drug discovery and design 7, 65-84, 1996
1111996
Age-related changes in the immune system of mice of eight medium and long-lived strains and hybrids. I. Organ, cellular, and activity changes
MMB Kay, J Mendoza, J Diven, T Denton, N Union, M Lajiness
Mechanisms of ageing and development 11 (5-6), 295-346, 1979
1021979
Systems chemical biology and the Semantic Web: what they mean for the future of drug discovery research
DJ Wild, Y Ding, AP Sheth, L Harland, EM Gifford, MS Lajiness
Drug discovery today 17 (9-10), 469-474, 2012
792012
Molecular similarity-based methods for selecting compounds for screening
MS Lajiness
Computational chemical graph theory, 299-316, 1990
771990
Hit-directed nearest-neighbor searching
V Shanmugasundaram, GM Maggiora, MS Lajiness
Journal of medicinal chemistry 48 (1), 240-248, 2005
682005
Enhancement of binary QSAR analysis by a GA-based variable selection method
H Gao, MS Lajiness, J Van Drie
Journal of Molecular Graphics and Modelling 20 (4), 259-268, 2002
672002
Implementing drug screening programs using molecular similarity methods.
MS Lajiness, MA Johnson, GM Maggiora
Progress in Clinical and Biological Research 291, 173-176, 1989
671989
Molecular similarity: a basis for designing drug screening programs
M Johnson, M Lajiness, G Maggiora
Progress in clinical and biological research 291, 167-171, 1989
631989
Four association coefficients for relating molecular similarity measures
Cheng, G Maggiora, M Lajiness, M Johnson
Journal of chemical information and computer sciences 36 (4), 909-915, 1996
481996
WENDI: a tool for finding non-obvious relationships between compounds and biological properties, genes, diseases and scholarly publications
Q Zhu, MS Lajiness, Y Ding, DJ Wild
Journal of cheminformatics 2, 1-9, 2010
402010
Evaluation of the performance of dissimilarity selection methodology
M Lajiness
QSAR: Rational approaches to the design of bioactive compounds, 201-204, 1991
401991
Dissimilarity-based approaches to compound acquisition
M Lajiness, I Watson
Current opinion in chemical biology 12 (3), 366-371, 2008
302008
Semantic inference using chemogenomics data for drug discovery
Q Zhu, Y Sun, S Challa, Y Ding, MS Lajiness, DJ Wild
BMC bioinformatics 12, 1-12, 2011
242011
A practical strategy for directed compound acquisition
GM Maggiora, V Shanmugasundaram, MS Lajiness, TN Doman, ...
Chemoinformatics in Drug Discovery 23, 317-332, 2005
242005
In SQAR: Rational Approaches to the Design of Bioactive Compounds; Silipo, C.; Vittoria, A., Eds
MS Lajiness
Elsevier: Amsterdam, 1991
141991
Capturing chemical information in an extended relational database system
TR Hagadone, MS Lajiness
Tetrahedron Computer Methodology 1 (3), 219-230, 1988
121988
The system can't perform the operation now. Try again later.
Articles 1–20